Executive Director William Garner now owns or exercises control over nearly 40% of common shares. The post Tryp Therapeutics Raises AUD$2.4 Million appeared...
Source: Streetwise Reports 04/26/2023 Algernon Pharmaceuticals Inc. has received a U.S. patent for a ground-breaking new Non-Alcoholic Steatohepatitis...
The compounds have shown positive results in pre-clinical studies. The post Mindset Pharma Files Patents for Nonhallucinogenic Psychedelic Drugs to Treat...
Silo's CEO wants to steer Oregon psilocybin operators away from a "dangerous cash-only system." The post Silo Wellness Looks to Crypto for Psilocybin Payment...
The acquisition is expected to generate revenue this year. The post Lobe Sciences Acquires Sickle Cell Drug Company Altemia appeared first on Green Market...
VANCOUVER – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-class psilocybin-based...
Source: Streetwise Reports 04/13/2023 Algernon Pharmaceuticals Inc. and its subsidiary Algernon NeuroScience have reached a new milestone...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, and PharmAla Biotech Holdings...
The capsules are GMP certified and will be used in clinical trials and by authorized patients The post PharmAla Biotech and Filament Health partner to...
Company plans to focus on alcohol use disorders. The post Clearmind Medicine Raises $3.5 Million appeared first on Green Market Report.